ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Surgeons Oncology Group Gets NCI Funding To Conduct Multicenter Clinical Trials

April 17, 1998

Advocacy: Journal Club Leader Sought By NBCC

August 22, 1997

Sledge Elected ASCO President

January 16, 2009

Psychiatric Society For Oncology/AIDS Formed; Holland Pres.

January 6, 1989

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

ACS Elects New Volunteer Leaders

November 19, 2010